Kineta targets viral and autoimmune diseases.
By Azam on December 15, 2008 Add a Comment
Kineta is a biotech start up targeting viral and autoimmune disease with a screening platform for bio switch to turn on immune defense. Kineta is founded by two former veterans Shawn Iadonato and Charles Magness from Illumigen Biosciences which was…
Continue Reading...Amyris Opens New Plant to Brew Some BioFuel
By Azam on November 11, 2008 1 Comment
Amyris Biotechnologies opened its first of two pilot plants to produce bio-based diesel from sugarcane. The 2.4 million gallon-capacity pilot plant in Emeryville is only expected to produce enough fuel for testing, experimenting and securing certification from the U.S. Environmental…
Continue Reading...DFine raised $30M for your back
By Azam on October 30, 2008 Add a Comment
DFine, Inc., a developer of minimally invasive solutions for treating vertebral compression fractures (VCFs), has secured a $30 million round of investment in its Series D funding. The round of funding was led by BBT Fund LP and Highland Capital…
Continue Reading...Cellective Raises $5M Bridge To $25M Series B
By Azam on October 28, 2008 Add a Comment 
CELLective Dx develops cancer diagnostic to analyze cancer form CTC form patients’ blood through bio chip diagnostic tools and using the dynamics of micro fluidic technology. Cellective Dx takes advantage of rare circulating tumour cells in cancer patients by bio chip…
Continue Reading...Calypso Medical Technologies has raised $20M in Venture debt for Cancer Radiation Devices
By Azam on September 18, 2008 Add a Comment 
Calypso Medical’s platform technology, referred to as GPS for the Body, provides clinicians with continuous, real-time tumor monitoring throughout the treatment process, without adding ionizing radiation. The company’s objective, real-time approach is providing a ‘missing link’ to clinicians for…
Continue Reading...ArKal Medical Raised $17.5M For Continuous Glucose Monitoring
By Azam on September 17, 2008 Add a Comment
ArKal Medical, Inc. raised $17.5 million in a Series B financing round led by Thomas McNerney & Partners. Existing investors, Delphi Ventures and MedVenture Associates were also significant investors in this round.
ArKal Medical is developing a novel continuous glucose…
Continue Reading...Condon Device: The Fabrication & Designing the Next Phase in Biolotechnology
By AZAM on March 25, 2008 Add a CommentCondon Devices is pioneering the efforts in synthetic biology field and leading a platform for new discovery in the field of biotechnology. The Cambridge, MA based company is in the forefront of technology used to Fabricate genomes using BioFAB platform…
Continue Reading...